Home » Stocks » CO

Global Cord Blood Corporation (CO)

Stock Price: $4.05 USD -0.08 (-1.94%)
Updated Jan 27, 2021 10:50 AM EST - Market open
Market Cap 506.26M
Revenue (ttm) 174.49M
Net Income (ttm) 67.25M
Shares Out 121.55M
EPS (ttm) 0.29
PE Ratio 13.82
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 27
Last Price $4.05
Previous Close $4.13
Change ($) -0.08
Change (%) -1.94%
Day's Open 4.13
Day's Range 4.03 - 4.15
Day's Volume 43,095
52-Week Range 2.56 - 4.97

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
PRNewsWire - 3 weeks ago

HONG KONG, Jan. 5, 2021 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell...

Seeking Alpha - 2 months ago

CO is a market leader with more net cash than the market cap and our price target is $6.00 [45% upside]. 1HFY2021 results saw total subscriber numbers grow by 10%, despite tough operating cond...

Seeking Alpha - 2 months ago

Global Cord Blood Corporation (CO) CEO Ting Zheng on Q2 2021 Results - Earnings Call Transcript

PRNewsWire - 2 months ago

HONG KONG, Nov. 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoieti...

GuruFocus - 3 months ago

Investors who are screening for value opportunities may want to consider the following stocks since their share prices are trading at a discount to the intrinsic value calculated by GuruFocus'...

Other stocks mentioned: LRCX, RTLR
PRNewsWire - 4 months ago

HONG KONG, Sept. 17, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoiet...

Seeking Alpha - 5 months ago

Global Cord Blood Corporation: June Quarter YoY EPS Of 22%, Subscriber Growth, And Total 183% Net Cash

Seeking Alpha - 5 months ago

Global Cord Blood Corporation (CO) CEO Tina Zheng on Q1 2021 Results - Earnings Call Transcript

PRNewsWire - 5 months ago

HONG KONG, Aug. 24, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoieti...

Seeking Alpha - 5 months ago

Global Cord Blood: 20% EPS 5-Year CAGR, 17% FCF Yield - Investing In A Business For Free

PRNewsWire - 5 months ago

HONG KONG, July 29, 2020 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) ("GCBC" or the "Company"), China's leading provider of cord blood collection, laboratory testing, hematopoieti...

Seeking Alpha - 6 months ago

Global Cord Blood Corporation (CO) CEO Tina Zheng on Q4 2020 Results - Earnings Call Transcript

InvestorPlace - 7 months ago

When looking for penny stocks to buy under $5, you’ve got to go dumpster diving. That’s never an easy task when stocks aren't cheap.

Other stocks mentioned: BBAR, GTX, III, MG, NMRK, ODP, OESX, SMSI, SVM
GuruFocus - 10 months ago

As investors continue grappling with coronavirus fears, three medical companies with high financial strength and trading below Peter Lynch’s valuation line of 15 times earnings are Bio-Rad Ind...

Other stocks mentioned: BIO, FONR
Market Watch - 11 months ago

Shares of Global Cord Blood Corp. CO, -0.61% were up 0.2% in premarket trading on Friday after the Hong Kong-based company said it expects a negative impact to its fourth-quarter performance d...

Seeking Alpha - 1 year ago

Global Cord Blood Corporation (CO) CEO Tina Zheng on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Global Cord Blood Corporation (CO) Management on Q1 2020 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Global Cord Blood Corporation (CO) Management on Q4 2019 Results - Earnings Call Transcript

Seeking Alpha - 1 year ago

Cordlife is proposing to merge with Global Cord Blood in what effectively is a reverse merger and a way to list Global Cord Blood on the Singaporean stock exchange.

About CO

Global Cord Blood Corporation, together with its subsidiaries, provides umbilical cord blood storage and ancillary services in the People's Republic of China. The company offers cord blood testing, processing, and storage services under the direction of subscribers; and tests, processes, and stores donated cord blood, as well as provides matching services. As of March 31, 2020, it had three operating cord blood banks in the Beijing municipality; one in the Guangdong province; and one in the Zhejiang province. The company was formerly known as C... [Read more...]

Industry
Diagnostics & Research
CEO
Ting Zheng
Employees
1,260
Stock Exchange
NYSE
Ticker Symbol
CO
Full Company Profile

Financial Performance

In 2019, CO's revenue was 1.22 billion, an increase of 23.79% compared to the previous year's 986.75 million. Earnings were 470.72 million, an increase of 61.69%.

Financial numbers in millions CNY.
Financial Statements